ArticleCurrent oncology (Toronto, Ont.)2023

Shorter Durations of Anti-HER2 Therapy for Patients with Early-Stage, HER2-Positive Breast Cancer: The Physician Perspective.

Michelle Bradbury et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.